Frank Douglas, MD, president and CEO of the Austen BioInnovation Institute in Akron, Ohio and Matthew Becker, MD, associate professor of polymer science at the University of Akron, discuss the business implications of biomaterials and the focus areas of the Austen BioInnovation Institute, which is a collaboration of five medical and educational institutions—Akron Children's Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Summa Health System, and The University of Akron. [Sponsored by Emdeon]